Ventas (VTR)
(Delayed Data from NYSE)
$62.11 USD
+0.99 (1.62%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $62.12 +0.01 (0.02%) 6:14 PM ET
3-Hold of 5 3
D Value C Growth D Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$62.11 USD
+0.99 (1.62%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $62.12 +0.01 (0.02%) 6:14 PM ET
3-Hold of 5 3
D Value C Growth D Momentum F VGM
Zacks News
Ventas, Inc. is a healthcare real estate investment trust (REIT) that is primarily engaged in acquisition and ownership of senior housing, R&I and healthcare properties, and leasing them to unaffiliated tenants or operating them through independent third-party managers. Ventas offers MOB management, leasing, marketing, facility development and advisory services to well-rated hospitals and health systems throughout the United States through its ownership interest in PMB Real Estate Services LLC and the company’s subsidiary, Lillibridge Healthcare Services, Inc. It also makes secured and non-mortgage loans and other investments relating to senior housing and healthcare properties or operators.
Regency Centers (REG) Q4 FFO Beats Estimates, Revenues Up
by Zacks Equity Research
Regency Centers (REG) witnesses rise in revenues in the fourth quarter of 2019, driven by an increase in lease income.
Equinix (EQIX) Q4 FFO Surpasses Estimates, Revenues Meet
by Zacks Equity Research
Equinix (EQIX) witnesses growth in revenues in the fourth quarter of 2019.
Healthpeak (PEAK) Q4 FFO Meets Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Healthpeak (PEAK) witnesses year-over-year growth in revenues in the fourth quarter of 2019.
Equinix (EQIX) Gears Up for Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Equinix's (EQIX) efforts to expand its International Business Exchange (IBX) platform are expected to have aided revenue growth in Q4.
DHC or VTR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
DHC vs. VTR: Which Stock Is the Better Value Option?
What's in the Offing for Healthpeak's (PEAK) Q4 Earnings?
by Zacks Equity Research
Healthpeak (PEAK) is expected to have benefited from transformation of its senior-housing operating portfolio (SHOP) asset quality in fourth-quarter 2019.
Near-Term Outlook Bleak for Equity REIT Stocks
by Moumita Chattopadhyay
Though a resilient economy and job-market gains infuse hopes for a number of asset categories, rising supply, property taxes and labor cost inflation are softening fundamentals of Equity REITs.
DHC or VTR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
DHC vs. VTR: Which Stock Is the Better Value Option?
OUTFRONT Media (OUT) Q3 FFO Lags, Revenues Beat Estimates
by Zacks Equity Research
OUTFRONT Media's (OUT) Q3 results aided by growth in revenues from national and local advertising, offset by mounting transit franchise and billboard lease expenses to some extent.
Annaly's (NLY) Q3 Earnings Miss Estimates on Declining NII
by Zacks Equity Research
Plummeting net interest income and fall in book value per share dampen Annaly's (NLY) Q3 results.
AGNC Investment's (AGNC) Stock Up 3.5% on Q3 Earnings Beat
by Zacks Equity Research
Growth in comprehensive income per common share and lower cost of funds buoy AGNC Investment's (AGNC) Q3 earnings.
Mack-Cali's (CLI) Q3 FFO Misses Estimates, Revenues Fall Y/Y
by Zacks Equity Research
Mack Cali's (CLI) Q3 results reflect slowdown in leasing activity in its office portfolio. Further, fall in same-store cash net operating income for the office portfolio play spoilsport.
American Tower (AMT) Surpasses Q3 AFFO & Revenue Estimates
by Zacks Equity Research
Encouraging growth in property segmental revenues and higher adjusted EBITDA drives American Tower's (AMT) Q3 performance.
HCP Tops Q3 FFO Estimate, Changes Name to Healthpeak Properties
by Zacks Equity Research
HCP, now renamed Healthpeak Properties, puts up an impressive show in third-quarter 2019 on the back of growth in the life-science and medical-office segments' net operating income.
Equinix (EQIX) Beats Q3 FFO Estimates, Misses on Revenues
by Zacks Equity Research
Equinix (EQIX) witnesses year-over-year growth in Q3 recurring revenues. Moreover, third quarter marks the 67th consecutive quarter of top-line improvement.
Mid-America Apartment's (MAA) Q3 AFFO Misses Estimates, NOI Up
by Zacks Equity Research
Mid-America Apartment (MAA) witnesses rent growth and increase in same-store net operating income in third-quarter 2019.
Boston Properties (BXP) Trumps Q3 FFO & Revenue Estimates
by Zacks Equity Research
Year-over-year occupancy growth in Boston Properties' (BXP) in-service office portfolio aids the company's Q3 performance.
UDR's Q3 FFOA & Revenues Beat Estimates, Occupancy Increases
by Zacks Equity Research
UDR puts up a decent show in Q3, with year-over-year growth in same-store net operating income and physical occupancy.
Vornado's (VNO) Q3 FFO Beat Estimates, Revenues Down Y/Y
by Zacks Equity Research
While Vornado Realty's (VNO) Q3 performance indicates dismal New York portfolio performance with decline in occupancy, strength in its 555 California property aid results.
Welltower's (WELL) Q3 FFO Beats Estimates, Revenues Up Y/Y
by Zacks Equity Research
Growth in same-store net operating income aids Welltower's (WELL) Q3 results, encouraging the company to raise its 2019 guidance.
Liberty Property (LPT) to be Sold to Prologis, Q3 FFO Flat Y/Y
by Zacks Equity Research
Liberty Property (LPT) agrees to be sold to Prologis in an all-stock deal. Also, with decent leasing activity and encouraging rent growth, the company puts up a decent show in Q3.
Ventas' (VTR) Q3 FFO Surpasses Estimates, Revenues Climb Y/Y
by Zacks Equity Research
Growth in same-store cash net operating income (NOI) for triple-net leased and office portfolios aid Ventas' (VTR) Q3 results.
The Zacks Analyst Blog Highlights: Tesla, Microsoft, Macy's, Dominion Energy and Ventas
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Tesla, Microsoft, Macy's, Dominion Energy and Ventas
SNH vs. VTR: Which Stock Is the Better Value Option?
by Zacks Equity Research
SNH vs. VTR: Which Stock Is the Better Value Option?
Ventas (VTR) Q3 FFO and Revenues Surpass Estimates
by Zacks Equity Research
Ventas (VTR) delivered FFO and revenue surprises of 2.13% and 3.79%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?